Cargando…
T46. THE EFFECT OF COMPREHENSIVE COGNITIVE REMEDIATION IN INDIVIDUALS AT ULTRA-HIGH RISK FOR PSYCHOSIS: A SINGLE-BLIND, RANDOMISED, CLINICAL TRIAL (FOCUS)
BACKGROUND: Individuals at ultra-high risk (UHR) for psychosis display significant cognitive deficits that constitute a barrier to functional recovery. Applying cognitive remediation (CR) before the onset of manifest psychosis may improve cognition and the clinical and functional prognosis of UHR in...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233880/ http://dx.doi.org/10.1093/schbul/sbaa029.606 |
_version_ | 1783535634753781760 |
---|---|
author | Birkedal Glenthoej, Louise Lise, Mariegaard Fagerlund, Birgitte Richardt Jepsen, Jens Dam Kristensen, Tina Wenneberg, Christina Krakauer, Kristine Medalia, Alice Roberts, David Hjorthøj, Carsten Nordentoft, Merete |
author_facet | Birkedal Glenthoej, Louise Lise, Mariegaard Fagerlund, Birgitte Richardt Jepsen, Jens Dam Kristensen, Tina Wenneberg, Christina Krakauer, Kristine Medalia, Alice Roberts, David Hjorthøj, Carsten Nordentoft, Merete |
author_sort | Birkedal Glenthoej, Louise |
collection | PubMed |
description | BACKGROUND: Individuals at ultra-high risk (UHR) for psychosis display significant cognitive deficits that constitute a barrier to functional recovery. Applying cognitive remediation (CR) before the onset of manifest psychosis may improve cognition and the clinical and functional prognosis of UHR individuals. METHODS: This randomised, clinical trial randomly assigned 146 UHR individuals aged 18–40 years to treatment as usual (TAU) or TAU plus cognitive remediation. The cognitive remediation consisted of 20-weeks of neurocognitive and social cognitive remediation. Assessments were carried out at 6- and 12-months post baseline. Primary outcome was composite score on the Brief Assessment of Cognition in Schizophrenia (BACS) battery at 6-months. RESULTS: Between April 2014 and January 2017, 73 UHR individuals were assigned to TAU and 73 were assigned to TAU + cognitive remediation. Compared to the control group, cognitive remediation did not result in significant improvement on the BACS composite score at 6-month follow-up (b=-0.125, 95%CI: -0.23 to 0.172, p=0.41). Nor did the intervention improve secondary outcomes in clinical symptoms or functioning. Exploratory analyses found emotion recognition latencies to be significantly more reduced in the intervention group than the TAU group at 6-months follow-up. At 12-month follow-up the intervention group exhibited significantly better performance on two exploratory outcomes of executive function and visual memory. The participants in the intervention group attended an average of 12 sessions out of 20. No adverse events were reported relating to the intervention. DISCUSSION: While the brief course of treatment did not impact global cognition, symptoms and functioning measures, treatment related benefit was found in exploratory component neuro- and social cognitive measures. Future studies should evaluate whether more personalized interventions such as the separate application of neurocognitive and social cognitive remediation may produce beneficial effect on cognition and functioning compared to treatment as usual, along with establishing the optimal number of training hours to produce cognitive and functional gains. |
format | Online Article Text |
id | pubmed-7233880 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-72338802020-05-23 T46. THE EFFECT OF COMPREHENSIVE COGNITIVE REMEDIATION IN INDIVIDUALS AT ULTRA-HIGH RISK FOR PSYCHOSIS: A SINGLE-BLIND, RANDOMISED, CLINICAL TRIAL (FOCUS) Birkedal Glenthoej, Louise Lise, Mariegaard Fagerlund, Birgitte Richardt Jepsen, Jens Dam Kristensen, Tina Wenneberg, Christina Krakauer, Kristine Medalia, Alice Roberts, David Hjorthøj, Carsten Nordentoft, Merete Schizophr Bull Poster Session III BACKGROUND: Individuals at ultra-high risk (UHR) for psychosis display significant cognitive deficits that constitute a barrier to functional recovery. Applying cognitive remediation (CR) before the onset of manifest psychosis may improve cognition and the clinical and functional prognosis of UHR individuals. METHODS: This randomised, clinical trial randomly assigned 146 UHR individuals aged 18–40 years to treatment as usual (TAU) or TAU plus cognitive remediation. The cognitive remediation consisted of 20-weeks of neurocognitive and social cognitive remediation. Assessments were carried out at 6- and 12-months post baseline. Primary outcome was composite score on the Brief Assessment of Cognition in Schizophrenia (BACS) battery at 6-months. RESULTS: Between April 2014 and January 2017, 73 UHR individuals were assigned to TAU and 73 were assigned to TAU + cognitive remediation. Compared to the control group, cognitive remediation did not result in significant improvement on the BACS composite score at 6-month follow-up (b=-0.125, 95%CI: -0.23 to 0.172, p=0.41). Nor did the intervention improve secondary outcomes in clinical symptoms or functioning. Exploratory analyses found emotion recognition latencies to be significantly more reduced in the intervention group than the TAU group at 6-months follow-up. At 12-month follow-up the intervention group exhibited significantly better performance on two exploratory outcomes of executive function and visual memory. The participants in the intervention group attended an average of 12 sessions out of 20. No adverse events were reported relating to the intervention. DISCUSSION: While the brief course of treatment did not impact global cognition, symptoms and functioning measures, treatment related benefit was found in exploratory component neuro- and social cognitive measures. Future studies should evaluate whether more personalized interventions such as the separate application of neurocognitive and social cognitive remediation may produce beneficial effect on cognition and functioning compared to treatment as usual, along with establishing the optimal number of training hours to produce cognitive and functional gains. Oxford University Press 2020-05 2020-05-18 /pmc/articles/PMC7233880/ http://dx.doi.org/10.1093/schbul/sbaa029.606 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Poster Session III Birkedal Glenthoej, Louise Lise, Mariegaard Fagerlund, Birgitte Richardt Jepsen, Jens Dam Kristensen, Tina Wenneberg, Christina Krakauer, Kristine Medalia, Alice Roberts, David Hjorthøj, Carsten Nordentoft, Merete T46. THE EFFECT OF COMPREHENSIVE COGNITIVE REMEDIATION IN INDIVIDUALS AT ULTRA-HIGH RISK FOR PSYCHOSIS: A SINGLE-BLIND, RANDOMISED, CLINICAL TRIAL (FOCUS) |
title | T46. THE EFFECT OF COMPREHENSIVE COGNITIVE REMEDIATION IN INDIVIDUALS AT ULTRA-HIGH RISK FOR PSYCHOSIS: A SINGLE-BLIND, RANDOMISED, CLINICAL TRIAL (FOCUS) |
title_full | T46. THE EFFECT OF COMPREHENSIVE COGNITIVE REMEDIATION IN INDIVIDUALS AT ULTRA-HIGH RISK FOR PSYCHOSIS: A SINGLE-BLIND, RANDOMISED, CLINICAL TRIAL (FOCUS) |
title_fullStr | T46. THE EFFECT OF COMPREHENSIVE COGNITIVE REMEDIATION IN INDIVIDUALS AT ULTRA-HIGH RISK FOR PSYCHOSIS: A SINGLE-BLIND, RANDOMISED, CLINICAL TRIAL (FOCUS) |
title_full_unstemmed | T46. THE EFFECT OF COMPREHENSIVE COGNITIVE REMEDIATION IN INDIVIDUALS AT ULTRA-HIGH RISK FOR PSYCHOSIS: A SINGLE-BLIND, RANDOMISED, CLINICAL TRIAL (FOCUS) |
title_short | T46. THE EFFECT OF COMPREHENSIVE COGNITIVE REMEDIATION IN INDIVIDUALS AT ULTRA-HIGH RISK FOR PSYCHOSIS: A SINGLE-BLIND, RANDOMISED, CLINICAL TRIAL (FOCUS) |
title_sort | t46. the effect of comprehensive cognitive remediation in individuals at ultra-high risk for psychosis: a single-blind, randomised, clinical trial (focus) |
topic | Poster Session III |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233880/ http://dx.doi.org/10.1093/schbul/sbaa029.606 |
work_keys_str_mv | AT birkedalglenthoejlouise t46theeffectofcomprehensivecognitiveremediationinindividualsatultrahighriskforpsychosisasingleblindrandomisedclinicaltrialfocus AT lisemariegaard t46theeffectofcomprehensivecognitiveremediationinindividualsatultrahighriskforpsychosisasingleblindrandomisedclinicaltrialfocus AT fagerlundbirgitte t46theeffectofcomprehensivecognitiveremediationinindividualsatultrahighriskforpsychosisasingleblindrandomisedclinicaltrialfocus AT richardtjepsenjens t46theeffectofcomprehensivecognitiveremediationinindividualsatultrahighriskforpsychosisasingleblindrandomisedclinicaltrialfocus AT damkristensentina t46theeffectofcomprehensivecognitiveremediationinindividualsatultrahighriskforpsychosisasingleblindrandomisedclinicaltrialfocus AT wennebergchristina t46theeffectofcomprehensivecognitiveremediationinindividualsatultrahighriskforpsychosisasingleblindrandomisedclinicaltrialfocus AT krakauerkristine t46theeffectofcomprehensivecognitiveremediationinindividualsatultrahighriskforpsychosisasingleblindrandomisedclinicaltrialfocus AT medaliaalice t46theeffectofcomprehensivecognitiveremediationinindividualsatultrahighriskforpsychosisasingleblindrandomisedclinicaltrialfocus AT robertsdavid t46theeffectofcomprehensivecognitiveremediationinindividualsatultrahighriskforpsychosisasingleblindrandomisedclinicaltrialfocus AT hjorthøjcarsten t46theeffectofcomprehensivecognitiveremediationinindividualsatultrahighriskforpsychosisasingleblindrandomisedclinicaltrialfocus AT nordentoftmerete t46theeffectofcomprehensivecognitiveremediationinindividualsatultrahighriskforpsychosisasingleblindrandomisedclinicaltrialfocus |